Stockreport

Kronos Bio Announces Selection of Autoimmune Development Candidate for Sjögren’s Disease

Kronos Bio, Inc.  (KRON) 
PDF – KB-7898, a p300 KAT inhibitor, is the Company's first development candidate for autoimmune diseases and originates from its proprietary discovery engine that decodes c [Read more]